You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Medtronic
Dow
McKesson
Johnson and Johnson

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

MULTIHANCE MULTIPACK Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Multihance Multipack patents expire, and what generic alternatives are available?

Multihance Multipack is a drug marketed by Bracco and is included in one NDA.

The generic ingredient in MULTIHANCE MULTIPACK is gadobenate dimeglumine. One supplier is listed for this compound. Additional details are available on the gadobenate dimeglumine profile page.

Summary for MULTIHANCE MULTIPACK
Drug patent expirations by year for MULTIHANCE MULTIPACK
Pharmacology for MULTIHANCE MULTIPACK

US Patents and Regulatory Information for MULTIHANCE MULTIPACK

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco MULTIHANCE MULTIPACK gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021358-001 Nov 23, 2004 RX Yes Yes   Start Trial   Start Trial   Start Trial
Bracco MULTIHANCE MULTIPACK gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021358-002 Nov 23, 2004 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MULTIHANCE MULTIPACK

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco MULTIHANCE MULTIPACK gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021358-001 Nov 23, 2004   Start Trial   Start Trial
Bracco MULTIHANCE MULTIPACK gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021358-002 Nov 23, 2004   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for MULTIHANCE MULTIPACK

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0230893 99C0013 Belgium   Start Trial PRODUCT NAME: GADOBENAATDIMEGLUMINE; NAT. REGISTRATION NO/DATE: 3503 IE 48 F 12 19990201; FIRST REGISTRATION: GB PL 06099/0006 19970722
0230893 SPC/GB97/081 United Kingdom   Start Trial PRODUCT NAME: GADOBENATE DIMEGLUMINE; REGISTERED: UK 06099/0006 19970722
0230893 33/1998 Austria   Start Trial PRODUCT NAME: GADOBENAT DIMEGLUMIN; NAT. REGISTRATION NO/DATE: 1-22773 19981109; FIRST REGISTRATION: GB PL 06099/0006 19970722
0230893 C980024 Netherlands   Start Trial PRODUCT NAME: GADOBEENZUUR,DESGEWENST IN DE VORM VAN EEN ZOUT MET EEN ALKA- LIMETAAL, AARDALKALIMETAAL, OF BASISCH GEPROTONEERD AMINOZUUR OF VAN EEN ALKYLAMMONIUM-, ALKANOLAMMONIUM- OF POLYHYDROXYAL- KYLAMMONIUMZOUT, IN HET BIJZONDER DIMEGLUMINI GADOBENAS; NAT. REGISTRATION NO/DATE: RVG 22324 19980706; FIRST REGISTRATION: GB PL 06099/0006 19970722
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
McKesson
Mallinckrodt
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.